JP2010526542A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526542A5
JP2010526542A5 JP2010507765A JP2010507765A JP2010526542A5 JP 2010526542 A5 JP2010526542 A5 JP 2010526542A5 JP 2010507765 A JP2010507765 A JP 2010507765A JP 2010507765 A JP2010507765 A JP 2010507765A JP 2010526542 A5 JP2010526542 A5 JP 2010526542A5
Authority
JP
Japan
Prior art keywords
nucleic acid
seq
cell
acid construct
transgenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010507765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526542A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2008/000692 external-priority patent/WO2008138072A1/en
Publication of JP2010526542A publication Critical patent/JP2010526542A/ja
Publication of JP2010526542A5 publication Critical patent/JP2010526542A5/ja
Ceased legal-status Critical Current

Links

JP2010507765A 2007-05-16 2008-05-16 インフルエンザの治療および予防 Ceased JP2010526542A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93831507P 2007-05-16 2007-05-16
AU2007902616A AU2007902616A0 (en) 2007-05-16 Treatment and prevention of influenza
PCT/AU2008/000692 WO2008138072A1 (en) 2007-05-16 2008-05-16 Treatment and prevention of influenza

Publications (2)

Publication Number Publication Date
JP2010526542A JP2010526542A (ja) 2010-08-05
JP2010526542A5 true JP2010526542A5 (enExample) 2011-06-30

Family

ID=40001608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507765A Ceased JP2010526542A (ja) 2007-05-16 2008-05-16 インフルエンザの治療および予防

Country Status (16)

Country Link
US (1) US20110209231A1 (enExample)
EP (2) EP2160466A4 (enExample)
JP (1) JP2010526542A (enExample)
KR (1) KR20100028038A (enExample)
CN (1) CN101918558B (enExample)
AU (1) AU2008250973B2 (enExample)
BR (1) BRPI0811870A2 (enExample)
CA (1) CA2687115A1 (enExample)
CO (1) CO6251333A2 (enExample)
EA (1) EA017948B1 (enExample)
IL (1) IL202126A (enExample)
MX (1) MX2009012317A (enExample)
MY (1) MY149171A (enExample)
NZ (2) NZ597601A (enExample)
WO (1) WO2008138072A1 (enExample)
ZA (1) ZA200908100B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012000565A2 (pt) * 2009-06-19 2016-11-16 Commw Scient Ind Res Org ensaio de vírus.
RU2599449C1 (ru) * 2011-12-15 2016-10-10 Байонир Корпорейшн Новые конъюгаты олигонуклеотидов и их применение
AU2013204327B2 (en) 2012-04-20 2016-09-01 Aviagen Cell transfection method
CN103966212A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用
KR101590997B1 (ko) 2014-01-13 2016-02-02 주식회사 엘지화학 불활성 입자가 코팅되어 있는 전극조립체를 포함하는 전지셀
ES2796930T3 (es) * 2014-01-23 2020-11-30 Univ Colorado State Res Found Silenciamiento de ARNip mediado por E. coli de la gripe aviar en pollos
KR20160076952A (ko) 2014-12-23 2016-07-01 김규리 문자 편집 장치 및 방법
AU2016305490B2 (en) 2015-08-07 2022-07-14 Commonwealth Scientific And Industrial Research Organisation Method for producing an animal comprising a germline genetic modification
WO2018187381A2 (en) 2017-04-03 2018-10-11 Sivec Biotechnologies, Llc A transkingdom platform for therapeutic nucleic acid delivery
CN109966497B (zh) * 2019-04-08 2021-03-12 中国医学科学院医药生物技术研究所 以ipan或其编码基因为靶点的物质在制备流感病毒抑制剂中的应用
CN111084154A (zh) * 2019-12-30 2020-05-01 集美大学 一种蛙类多层养殖装置
KR102584623B1 (ko) * 2023-03-08 2023-10-06 대한민국 오리 유래 rna 폴리머라제 i 프로모터 및 이를 포함하는 재조합 벡터

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504729A (en) * 1980-11-05 1985-03-12 Babcock-Hitachi Kabushiki Kaisha Three o'clock welding method in narrow groove
US4501729A (en) 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
US4883750A (en) * 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4903635A (en) * 1986-07-02 1990-02-27 Embrex, Inc. High speed automated injection system for avian embryos
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5162215A (en) * 1988-09-22 1992-11-10 Amgen Inc. Method of gene transfer into chickens and other avian species
US5056464A (en) 1990-01-18 1991-10-15 Embrex, Inc. Automated injection system for avian embryos with advanced fluid delivery system
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5283185A (en) 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5136979A (en) 1991-09-25 1992-08-11 Embrex, Inc. Modular injection system for avian embryos
US5641656A (en) * 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5932241A (en) 1995-06-07 1999-08-03 Valentis, Incorporated Cationic lipid DNA complexes for gene targeting
US8202979B2 (en) * 2002-02-20 2012-06-19 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
US7067308B1 (en) 2000-03-28 2006-06-27 Bioagri Corporation Vector for genetically modifying non-human animals
CA2433680A1 (en) * 2000-12-28 2002-08-01 Gregory M Arndt Double-stranded rna-mediated gene suppression
US7145057B2 (en) 2002-02-01 2006-12-05 Origen Therapeutics, Inc. Chimeric bird from embryonic stem cells
AU2003266014B2 (en) 2002-05-06 2009-05-14 Alnylam Pharmaceuticals, Inc. Methods for delivery of nucleic acids
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
US20040242518A1 (en) * 2002-09-28 2004-12-02 Massachusetts Institute Of Technology Influenza therapeutic
US20060160759A1 (en) * 2002-09-28 2006-07-20 Jianzhu Chen Influenza therapeutic
AU2003279004B2 (en) * 2002-09-28 2009-10-08 Massachusetts Institute Of Technology Influenza therapeutic
WO2006026238A2 (en) * 2004-08-25 2006-03-09 Avigenics, Inc. Rna interference in avians
US20080222743A1 (en) * 2004-08-25 2008-09-11 Avigenics, Inc. RNA interference and disease resistance in avians
US7617795B2 (en) 2004-10-13 2009-11-17 Embrex, Inc. Methods and apparatus for injecting and sampling material through avian egg membranes
WO2006084035A2 (en) 2005-02-01 2006-08-10 Origen Therapeutics, Inc. Transgenic chickens
RU2533804C2 (ru) * 2005-03-31 2014-11-20 Ронен КАХАНА Получение домашней птицы и других животных, устойчивых к вирусному заболеванию
KR20070118703A (ko) * 2005-04-08 2007-12-17 나스텍 파마수티컬 컴퍼니 인코포레이티드 호흡기 바이러스 감염을 치료하는 알엔에이 아이
US7199109B2 (en) * 2005-06-03 2007-04-03 Cal Poly Pomona Foundation Potent inhibition of influenza virus by specifically designed short interfering RNA
US20070099858A1 (en) * 2005-10-03 2007-05-03 Sirna Therapeutics, Inc. RNA interference mediated of inhibition of influenza virus gene expression using short interfering nucleic acid (siNA)
CA2627585A1 (en) * 2005-11-01 2007-05-10 Alnylam Pharmaceuticals, Inc. Rnai inhibition of influenza virus replication

Similar Documents

Publication Publication Date Title
JP2010526542A5 (enExample)
Prangishvili et al. Exceptionally diverse morphotypes and genomes of crenarchaeal hyperthermophilic viruses
CN104651398A (zh) 利用CRISPR-Cas9特异敲出microRNA基因家族的方法
JP2007527244A5 (enExample)
Hasslung et al. Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN-α production by porcine PBMCs
RU2008145226A (ru) Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
NZ597601A (en) Treatment and prevention of influenza
JP2013538554A5 (enExample)
Sangsuriya et al. Construction and application of a protein interaction map for white spot syndrome virus (WSSV)
TW201819400A (zh) 合成之嵌合痘病毒
CN111979273A (zh) 一种制备人源化ace2小鼠模型的方法
Li et al. Identification, cloning and characterization of an extracellular signal-regulated kinase (ERK) from Chinese shrimp, Fenneropenaeusáchinensis
CN112760320B (zh) 有效抑制猪流行性腹泻病毒复制的外源性人工miRNA及其用途
CN115820638B (zh) 一种抑制水禽源禽呼肠孤病毒复制的外源性人工miRNA及其应用
CN114058619B (zh) Riplet敲除细胞系的构建及作为小核糖核酸病毒科病毒疫苗生产细胞系的应用
Kim et al. Specific nucleotides at the 3′-terminal promoter of viral hemorrhagic septicemia virus are important for virulence in vitro and in vivo
JP2011504741A5 (enExample)
Jiao et al. Transgenically mediated shRNAs targeting conserved regions of foot-and-mouth disease virus provide heritable resistance in porcine cell lines and suckling mice
Salazar et al. Involvement of selected cellular miRNAs in the in vitro and in vivo infection of infectious salmon anemia virus (ISAV)
Alencar et al. Modifications of the nucleoprotein of viral haemorrhagic septicaemia virus showed gain of virulence in intraperitoneally infected rainbow trout
CN103589693A (zh) 一种表达ibdv vp2和法氏囊素三肽嵌合蛋白重组火鸡疱疹病毒
CN100345965C (zh) 能抑制口蹄疫病毒复制与感染的siRNA及其制备方法
Loy et al. Characterization of newly revealed sequences in the infectious myonecrosis virus genome in Litopenaeus vannamei
Lin et al. CRISPR/Cas Technology in Disease Prevention and Control of Aquatic Animals
CN114606262A (zh) 一种基因敲除载体及其构建方法与用途